HomeFHTX • NASDAQ
add
Foghorn Therapeutics Inc.
Previous close
$7.83
Day range
$7.50 - $7.91
Year range
$2.70 - $10.25
Market cap
434.88M USD
Avg Volume
205.60K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 6.89M | 23.02% |
Operating expense | 31.12M | -17.34% |
Net income | -22.98M | 22.07% |
Net profit margin | -333.61 | 36.65% |
Earnings per share | -0.45 | 35.71% |
EBITDA | -23.44M | 24.80% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 285.18M | 0.30% |
Total assets | 328.58M | -3.24% |
Total liabilities | 342.91M | -11.83% |
Total equity | -14.32M | — |
Shares outstanding | 55.33M | — |
Price to book | -30.12 | — |
Return on assets | -20.76% | — |
Return on capital | 434.10% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -22.98M | 22.07% |
Cash from operations | -25.54M | 20.63% |
Cash from investing | -17.98M | -145.93% |
Cash from financing | 103.21M | 100,100.00% |
Net change in cash | 59.69M | 745.28% |
Free cash flow | -11.69M | 31.59% |
About
Founded
2015
Website
Employees
116